KTTA Pasithea Therapeutics
- 6.6000
- +0.1000+1.54%
Pasithea Therapeutics News
12 Health Care Stocks Moving In Friday's Intraday Session
GainersAkanda (NASDAQ:AKAN) shares increased by 103.8% to $0.27 during Friday's regular session. The company's market cap stands at $8.6 million. NovaBay Pharmaceuticals (AMEX:NBY) shares rose 48.66%
10-Q: Quarterly report
Pasithea Therapeutics Announces PAS-004 Abstract Accepted for Poster Presentation at 2024 ASCO Annual Meeting
SOUTH SAN FRANCISCO, Calif. and MIAMI, April 29, 2024 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) ("Pasithea" or the "Company"), a clinical-stage biotechnology company developing
Express News | Pasithea Therapeutics Announces the First Cohort Has Completed the Initial Dosing in Its Phase 1 Trial Evaluating Pas-004 in Ras, Nf1 and Raf Mutated Cancers
Pasithea Therapeutics Begins U.S. Trial for Cancer Treatment
Pasithea Therapeutics Announces Opening Of Enrollment In The U.S. For Its Phase 1 Trial Of PAS-004
-- Activation of four U.S. sites for Phase 1 clinical trial of PAS-004 to evaluate safety, dose, key biomarker data and preliminary efficacy ---- Plans to open three additional sites in Eastern Europe
Top Premarket Decliners
VCI Global (VCIG) shares slumped more than 36% Friday premarket after the company priced a $2.8 million offering of stock and warrants. SEALSQ (LAES) shares tumbled 23%, a day after the company closed
Pasithea Therapeutics Shares Rise on FDA Clearance to Evaluate PAS-004 in Advanced Cancer Patients
Pasithea Therapeutics (KTTA) shares rose 12% in recent Tuesday trading after the company got US Federal Drug Administration clearance to assess PAS-004 in cancer patients with advanced solid tumors. P
Pasithea Conducts 1-for-20 Reverse Stock Split, Gets FDA Okay for Study
Pasithea Therapeutics Shares Resume Trade
Pasithea Therapeutics Shares Resume Trade
Express News | Pasithea Therapeutics Announces FDA Acceptance Of IND Application To Evaluate PAS-004 In Advanced Cancer Patients
Pasithea Therapeutics Announces FDA Acceptance of IND Application to Evaluate PAS-004 in Advanced Cancer Patients
-- PAS-004 is the first macrocyclic MEK inhibitor to enter human clinical trials -- -- Phase 1 dose escalation study in patients with MAPK pathway driven advanced solid tumors to begin in Q1 2024 – -- Initial readout
Pasithea Therapeutics To Carry Out 1-for-20 Reverse Stock Split On January 2nd, 2024
December 29th - $Pasithea Therapeutics(KTTA.US)$ is about to implement a 1-for-20 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from January 2nd, 2024.$Pasithe
Press Release: Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023
Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023 SOUTH SAN FRANCISCO, Calif. and MIAMI, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics C
Pasithea Therapeutics Corp Announces 1-For-20 Reverse Stock Split; Anticipates Common Stock Will Begin Trading On A Reverse Stock Split-Adjusted Basis At Market Open On January 2, 2024
- SEC FilingOn December 28, 2023, Pasithea Therapeutics Corp. (the "Company") filed a Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company with the Secretar
12 Health Care Stocks Moving In Monday's Intraday Session
GainersJin Medical International (NASDAQ:ZJYL) shares moved upwards by 94.4% to $137.0 during Monday's regular session. The market value of their outstanding shares is at $1.0 billion. Karuna Therapeu
Press Release: Pasithea Therapeutics Announces Results From 2023 Annual Meeting
Pasithea Therapeutics Announces Results from 2023 Annual Meeting -- Solicitation Continues for Certain Charter Amendment Proposals -- SOUTH SAN FRANCISCO, Calif. and MIAMI, Dec. 19, 2023 (GLOBE NEWS
Wall Street Set to Open Slightly Higher Tuesday; Annual Inflation Declines to 3.1%
US stocks look set to open flat to slightly higher in Tuesday's trading session as investors parse inflation data that came out earlier in the morning and look to the start of the Federal Reserve's tw
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersC4 Therapeutics (NASDAQ:CCCC) stock rose 59.7% to $1.89 during Tuesday's pre-market session. The company's market cap stands at $92.8 million. Candel Therapeutics (NASDAQ:CADL) stock increased
12 Health Care Stocks Moving In Monday's After-Market Session
GainersConnect Biopharma Hldgs (NASDAQ:CNTB) shares increased by 51.1% to $1.36 during Monday's after-market session. The market value of their outstanding shares is at $74.8 million. IN8bio (NASDAQ:I
Analysis
Price Target
No Data
